• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR
Click for more information
3.51% 27.5¢

PARADIGM BIOPHARMACEUTICALS LIMITED..

Market Cap $96.19M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. It is... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. It is engaged in researching and developing therapeutic products for human use. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS clears cellular and tissue accumulation of GAGs. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with mucopolysaccharidoses (MPS); treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
Where we at?
6 7 8
14:09 465 140K
14:09 Last post  goldmad Comments Created with Sketch.  465  Views Created with Sketch.  140K 
PAR
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		01/05/24 25 8.6K
01/05/24 Last post  Denial Comments Created with Sketch.  25  Views Created with Sketch.  8.6K 
PAR
lowest ever 		30/04/24 0 378
30/04/24 Last post  bobsee Comments Created with Sketch.  0  Views Created with Sketch.  378 
PAR
OARSI 2024
2
29/04/24 86 31K
29/04/24 Last post  Willem007 Comments Created with Sketch.  86  Views Created with Sketch.  31K 
PAR
Ann: Notification of cessation of securities - PAR 		26/04/24 0 406
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  406 
PAR
General OA media and info
10 11 12
24/04/24 670 250K
24/04/24 Last post  Mozzarc Comments Created with Sketch.  670  Views Created with Sketch.  250K 
PAR
Capital Raise 		23/04/24 29 8.8K
23/04/24 Last post  bobsee Comments Created with Sketch.  29  Views Created with Sketch.  8.8K 
PAR
2x2 Yay Or Nay From The FDA? 		22/04/24 13 4.2K
22/04/24 Last post  Mozzarc Comments Created with Sketch.  13  Views Created with Sketch.  4.2K 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:54
 
Notification of cessation of securities - PAR
26 Apr 16:46
 
Type D Response Submitted and Received by the US FDA
19 Apr 08:36
 
Notification of cessation of securities - PAR
05 Apr 19:49
 
PAR to present at NWR Healthcare Conference
20 Mar 14:45
 
Change of Director's Interest Notice
08 Mar 13:18
 
View More arrow Created with Sketch.

Featured News

LU7 Lithium Universe ends the quarter on the charge for Quebec Refinery development
right-arrow Created with Sketch.
RNT Rent.com.au hits $250M in RentPay payments as housing crisis rolls on
right-arrow Created with Sketch.
NEWS Quarterly Wrap: Frontier Energy & Haranga Resources
right-arrow Created with Sketch.
LU7 Lithium Universe visits China's Jiangsu Li-Carb facility to shore up design specifics
right-arrow Created with Sketch.
BPH BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11
right-arrow Created with Sketch.
TEA Newest ASX entrant, Tasmea Ltd, up 12.5% on maiden debut
right-arrow Created with Sketch.
(20min delay)
Last
27.5¢ 		Change
-0.010(3.51%) 		Mkt cap ! $96.19M
Open High Low Value Volume
30.0¢ 30.0¢ 27.0¢ $45.01K 159.2K

Buyers (Bids)

No. Vol. Price($)
3 17942 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 9634 1
View Market Depth
Last trade - 16.10pm 02/05/2024 (20 minute delay) ?
Last
27.5¢ 		  Change
-0.010 ( 3.51 %)
Open High Low Volume
29.0¢ 29.0¢ 27.0¢ 41613
Last updated 15.59pm 02/05/2024 ?
PAR (ASX) Chart

Top Stories

Lithium Universe ends the quarter charged up for Quebec Refinery roll-out

Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.

Featured News

NEWS Quarterly Wrap: Frontier Energy & Haranga Resources
right-arrow Created with Sketch.
NEWS Quarterly Wrap: Infini Resources, Barton Gold & Infinity Lithium
right-arrow Created with Sketch.
TEA Newest ASX entrant, Tasmea Ltd, up 12.5% on maiden debut
right-arrow Created with Sketch.
BB1 Why Princeton Professor rates BlinkLab's autism & ADHD screening app
right-arrow Created with Sketch.
NEWS Dreadnought hits expected mineralisation through drilling at Yilgarn targets
right-arrow Created with Sketch.
NEWS Wealth Within eyes healthcare sector strength
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.